Related Experiment Video
Updated: Feb 14, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Slug-mucus-inspired single-cell coating enhances the treatment of inflammatory bowel disease by improving probiotic
Jinfan Yang1, Jiachen Wang2, Ning Shang1
1National Demonstration Center for Experimental Light Chemistry Engineering Education, Shaanxi Provincial Key Laboratory of Papermaking Technology and Specialty Paper Development, College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an, 710021, China; Comprehensive Breast Center, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Abstract:
Probiotics alleviate symptoms of inflammatory bowel disease (IBD), metabolic disorders, and cardiovascular disorders by modulating the gut microbiota. However, oral probiotics face significant survival challenges due to the protective environment of the gastrointestinal tract. Inspired by the strong reparative properties and adhesive features of slug mucus, we developed a biomimetic universal single-cell coated probiotics system (AC-EcN), and the single-cell coating provides strong adhesion, durability, and self-healing after shear stress, with a double-layer network structure. Consequently, it provides prolonged protection (over 96 h) against gastrointestinal barriers, significantly enhancing probiotic proliferation in the intestines and achieving sustained cumulative effects with multiple oral administrations. Additionally, AC-EcN can selectively aggregate in response to inflammation, thereby amplifying the therapeutic benefits of probiotics. This process modulates intestinal inflammation, rapidly restores intestinal barrier function, and alters intestinal microbial community structure. Fundamentally reestablishing a healthy colonic state and reversing IBD. This probiotic single-cell coating strategy, which improves probiotic colonization efficiency, significantly enhances the treatment of IBD as a universal approach to potentiate orally administered probiotics.
More Related Videos
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
06:06Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...